The historical rank and industry rank for TherapeuticsMD's FCF Margin % or its related term are showing as below:
TXMD'
s FCF Margin % Range Over the Past 10 Years
Min: -5632.18 Med: -372.77 Max: 81.2
Current: 80.5
During the past 13 years, the highest FCF Margin % of TherapeuticsMD was 81.20%. The lowest was -5632.18%. And the median was -372.77%.
TXMD's FCF Margin % is ranked better than 99.58% of 958
companies
in the Drug Manufacturers industry
Industry Median: 2.51
vs TXMD: 80.50
TherapeuticsMD FCF Margin % Related Terms
TherapeuticsMD FCF Margin % Historical Data
* Premium members only.
The historical data trend for TherapeuticsMD's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, TherapeuticsMD's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TherapeuticsMD FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, TherapeuticsMD's FCF Margin % distribution charts can be found below:
* The bar in red indicates where TherapeuticsMD's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TherapeuticsMD (TXMD) has a FCF Margin % of 130.39% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on TherapeuticsMD and its competitors. According to the industry distribution chart, TherapeuticsMD ranks #4 out of 958 companies in the Drug Manufacturers industry, placing it in the top 0.40000000000001%.
Is TherapeuticsMD's FCF Margin % too high?
TherapeuticsMD's current FCF Margin % is 130.39%. The Drug Manufacturers industry median FCF Margin % is 2.51. TherapeuticsMD's value of 130.39% is 5094.8% above this industry median. Based on the distribution chart, TherapeuticsMD ranks #4 out of 958 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, TherapeuticsMD has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does TherapeuticsMD's FCF Margin % compare to AYTU and KAYS?
According to the Drug Manufacturers industry distribution chart, TherapeuticsMD ranks #4 out of 958 companies for FCF Margin %. This places TherapeuticsMD in the top 0% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.51. TherapeuticsMD's value of 130.39% is 5094.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TherapeuticsMD's current FCF Margin % of 130.39% is 5094.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on TherapeuticsMD and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TherapeuticsMD's current FCF Margin % is 130.39%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TherapeuticsMD stock overvalued right now?
Based on GuruFocus' analysis, TherapeuticsMD (TXMD) is currently considered Fairly Valued. The stock's GF Value™ is $2.07, compared to a current price of $2.02 — trading 2.4% below its estimated fair value. The current FCF Margin % is 130.39% and 5094.8% above the Drug Manufacturers industry median of 2.51. TherapeuticsMD's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For TherapeuticsMD (TXMD), the current FCF Margin % is 130.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TherapeuticsMD (TXMD) Overvalued in 2026?
Based on GuruFocus' analysis, TherapeuticsMD stock appears to be undervalued.
The current stock price of $2.02 is trading 2.4% below its estimated GF Value™ of $2.07.
GuruFocus considers TherapeuticsMD to be Fairly Valued.
Key valuation signals for TXMD:
FCF Margin %: 130.39%
GF Value™: $2.07 vs. price of $2.02 (2.4% below fair value)
Industry Position: 5094.8% above the Drug Manufacturers median (#4 of 958)
No single metric tells the full story. See the TXMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.
55GF Score
Get the complete analysis for TXMD
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TXMD has been successfully added to your 
